 |
| CrossRef Text and Data Mining |
| Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining. |
| Role of Potassium-competitive Acid Blockers in the Treatment of Gastric Acid-related Disorders |
| Mun Young Cho, Yu Kyung Cho |
|
Korean J Helicobacter Up Gastrointest Res. 2023;23(3):167-173. Published online September 8, 2023 DOI: https://doi.org/10.7704/kjhugr.2023.0043 |
|
Role of Potassium-competitive Acid Blockers in the Treatment of Gastric Acid-related Disorders The Korean Journal of Helicobacter and Upper Gastrointestinal Research. 2023;23(3):167-173  Review article: potassium‐competitive acid blockers for the treatment of acid‐related disorders Alimentary Pharmacology & Therapeutics. 2021;53(7):794-809 Treatment of Acid-related Diseases Using Potassium-competitive Acid Blockers The Korean Journal of Gastroenterology. 2022;80(6):247-253 Potassium-competitive acid blockers: Advanced therapeutic option for acid-related diseases Pharmacology & Therapeutics. 2016;168:12-22 Potassium-Competitive Acid Blockers (P-CABs): Are They Finally Ready for Prime Time in Acid-Related Disease? Clinical and Translational Gastroenterology. 2015;6(10):e119 Acid Suppressant Therapy: a Step Forward with Potassium-Competitive Acid Blockers Current Treatment Options in Gastroenterology. 2021;19(1):94-132 Editorial: potassium‐competitive acid blockers—is there a role for more complete acid suppression? Alimentary Pharmacology & Therapeutics. 2022;56(6):1071-1071 Correction to: Acid Suppressant Therapy: a Step Forward with Potassium-Competitive Acid Blockers Current Treatment Options in Gastroenterology. 2021;19(1):133-133 Editorial: potassium‐competitive acid blockers for acid‐related diseases—tegoprazan, a new kid on the block Alimentary Pharmacology & Therapeutics. 2019;50(8):960-962 Editorial: potassium competitive acid blockers—is there a role for more complete acid suppression? Authors' reply Alimentary Pharmacology & Therapeutics. 2022;56(6):1072-1073 |
